Zu anderen Kryptowährungen navigieren

RNAMAvidity Biosciences, Inc.

Schnellzugriffe

Positionsrechner

Positionsgröße (USD)HebelBeginnen Sie den Handel mit {leverage}x Hebel

Avidity Biosciences, Inc.

RNAM

$0.0000

+0.00% (24h)

AktienStufe C1000x Hebel

Wichtige Erkenntnisse

Zuletzt aktualisiert:: 2026-04-13

•Replimune (REPLI) closed at $4.76 on April 10, 2026 — a ~20% single-day drop and 51% YTD decline following a second FDA Complete Response Letter for RP1.
•Leverage risk is extreme: a 50x long CFD opened at $5.91 would have been liquidated intraday, as the 20% decline represents ~10x the initial margin at that leverage level.
•A February 2026 SEC filing warned a second rejection could make RP1 development 'no longer viable,' with Phase 3 completion not expected until January 2029.
•Cross-market contagion targets biotech ETFs (XBI, IBB) as the FDA rejection reinforces sector-wide regulatory uncertainty flagged by nearly half of RBC Capital Markets-surveyed investors.
•FDA leadership transition (Vinay Prasad departing by end of April 2026) adds short-term regulatory uncertainty across clinical-stage oncology names.

Preis & Marktstruktur

Diagramm wird geladen...

Status des Handelsregimes

Hebel

1000x

(Maximum auf CoinUnited.io)

Volatilität

N/A

Glossar

Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.

Stock CFD	A contract for difference on a share price — price exposure only, not ownership of the underlying shares.
Extended hours	Pre-market and after-hours trading outside the exchange’s regular session.
Basis risk	The risk that the CFD reference price and the exchange execution price do not move in step.
P/E	Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge.
Gross margin	Gross profit ÷ revenue; reflects product-level profitability.
EPS	Earnings per share = net income ÷ diluted shares outstanding.

Neueste Impulse

2026-04-13AktienBärisch

RNAM

Replimune Stürzt YTD um 56% Nach Zweiter FDA-Abweisung: Hebelrisiken und Ansteckung im Biotech-Sektor

Wie von FierceBiotech und BioPharma Dive berichtet, hat die U.S. Food and Drug Administration am 10. April 2026 ein zweites Complete Response Letter (CRL) herausgegeben und die RP1 (vusolimogene oderp

2026-04-11AktienBärisch

RNAM

Replimune's Second FDA Rejection: Layoffs Signal Binary-Risk Collapse for Biotech CFD Traders

On April 10, 2026, the U.S. Food and Drug Administration issued a second Complete Response Letter (CRL) rejecting Replimune Group, Inc.'s (NASDAQ: REPL) resubmitted Biologics License Application for R

2026-04-10AktienVolatil

RNAM

Replimune's RP1 Faces Second FDA Verdict: What April 10 Means for Biotech CFD Traders

Replimune Group Inc. (NASDAQ: REPL) received a Complete Response Letter (CRL) from the FDA on July 22, 2025, rejecting its Biologics License Application for RP1 — an oncolytic herpes simplex virus — i

Alle RNAM Impulse anzeigen

Get Started with Avidity Biosciences, Inc.

Start trading Avidity Biosciences, Inc. on CoinUnited.io with industry-leading leverage and zero fees.

Trade with Leverage

Trade RNAM CFDs with up to 1000x leverage on CoinUnited.io.

Up to 1000x leverage
Zero trading fees
Advanced risk management tools

Trade RNAM Now

Explore Stocks

Browse the full stocks market on CoinUnited.io with 125+ instruments.

125+ stocks instruments
Real-time market data
Professional charting tools

Browse Stocks

Learn Stocks Trading

Read our in-depth research and analysis on stocks markets.

Expert market analysis
Technical analysis basics
Daily market insights

Read Our Research

How to Trade Avidity Biosciences, Inc.: Step-by-Step Guide

Learn how to trade Avidity Biosciences, Inc. (RNAM) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.

Create Your CoinUnited.io Account

✓Quick and free registration
✓Email and password setup
✓Two-factor authentication for security

Verify Your Identity

Complete the KYC verification process to unlock full trading features and higher limits.

✓Upload government-issued ID
✓Proof of address document
✓Usually verified within minutes

Deposit Funds

Fund your account using one of the supported deposit methods.

Deposit Methods

•Cryptocurrency deposits (BTC, ETH, USDT)
•Bank transfer available
•No minimum deposit requirement

Find RNAM in the Stocks Section

Navigate to the stocks market section and search for RNAM. You can trade Avidity Biosciences, Inc. as a CFD with up to 1000x leverage.

✓Search for "RNAM" in the trading platform
✓Select CFD trading mode
✓Review the current price and market data

Place Your Trade

Choose your position direction (long or short), set your leverage, and enter your position size to trade Avidity Biosciences, Inc..

✓Long (buy) if you expect RNAM to rise
✓Short (sell) if you expect RNAM to fall
✓Set stop-loss and take-profit levels

Monitor & Manage Risk

Keep track of your open positions and manage risk with stop-loss orders and position sizing.

✓Monitor P&L in real-time
✓Adjust stop-loss as needed
✓Never risk more than you can afford to lose

Order Types

Market Order

Execute immediately at the current market price. Best for quick entries.

Limit Order

Set a specific price to enter. The order fills only when the market reaches your price.

Stop-Loss Order

Automatically close your position at a specified price to limit potential losses.

Important Tips

• Start with a small position to understand how leverage works
• Always set a stop-loss to protect your capital
• Higher leverage amplifies both gains and losses
• Never invest more than you can afford to lose

Bereit, Avidity Biosciences, Inc. zu handeln?

Bis zu 1000x Hebel

Handeln Sie RNAM jetzt

Symbol

RNAM

Märkte

Aktien

Sektor

General

CU-Produktcode

RNAM

Similar Stocks Assets

Explore other stocks instruments in the same sector as Avidity Biosciences, Inc.. Compare performance and find trading opportunities.

ProShares UltraShort Silver

$24.60

▲8.5%

AeroVironment, Inc.

$158.21

▼8.5%

Tempus AI, Inc

$66.47

▲8.4%

Ondas Holdings Inc.

$8.32

▼6.6%

TransUnion

$64.23

▼6.5%

View all General →

Über den Autor

CoinUnited.io Research Team

This Avidity Biosciences, Inc. page is compiled by CoinUnited.io's research team: analysts covering listed equities and global markets, working from primary filings and named third-party data rather than opinion.

Unsere Forschungs-Methodik

Every figure is traced to a primary or named third-party source and dated: financial statements from the company’s SEC filings, institutional ownership from Form 13F, analyst targets from aggregated third-party coverage, and market data from the CoinUnited reference price. The Source Map on this page lists each one with its source and the date we last checked it.

Disclaimer: content is for informational and educational purposes only and is not personalized financial advice. A stock CFD carries significant risk and provides price exposure only, not equity ownership. Always conduct your own research and consult a qualified financial advisor.

Haftungsausschlüsse & Verweise

Wichtiger Haftungsausschluss zum Risiko

A CoinUnited stock CFD gives price exposure to Avidity Biosciences, Inc. only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.

Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.

Benutzer sollten eigene Recherchen durchführen und sich vor Investitionsentscheidungen mit qualifizierten Finanzexperten beraten. Die Ersteller und Betreiber dieser Plattform übernehmen keine Verantwortung für finanzielle Verluste oder sonstige Schäden, die aus der Verwendung der bereitgestellten Informationen entstehen könnten.

Leveraged trading is extremely risky and you may lose your entire deposit.

Methodologie-Übersicht

Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.

Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
Market data: the CoinUnited reference price and daily closes
Institutional ownership: SEC Form 13F quarterly filings
Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
Peer multiples: third-party trailing-twelve-month ratios

CoinUnited does not publish a price forecast or target for Avidity Biosciences, Inc..

Letzte Überprüfung der Methodologie:

Bereit, mit dem Handel von Avidity Biosciences, Inc. zu beginnen?

Schließen Sie sich Tausenden von Händlern an und beginnen Sie noch heute Ihre Handelsreise mit Avidity Biosciences, Inc.. Erhalten Sie Zugang zu fortschrittlichen Handelswerkzeugen und wettbewerbsfähigen Gebühren.

Handel RNAM/USDT Jetzt anmelden